Biological warfare defense vaccine research and development program: hearing before the Subcommitttee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, October 23, 2001, Volumen4U.S. Government Printing Office, 2002 - 129 páginas |
Otras ediciones - Ver todas
Términos y frases comunes
American anthrax vaccine antibiotics antigen areas AVANT biodefense biological defense biological warfare BioPort biotechnology industry bioterrorism biowarfare Chairman Christopher Shays Cipro clinical trials committee companies CONGRESS THE LIBRARY Congressman currently defense vaccines Department of Defense disease doses drugs effective efficacy EluSys evaluate FAUCI FDA approved filter changes going HHS Readiness human immune issue KINGSBURY KUCINICH LANTOS LIBRARY OF CONGRESS licensed manufacturing practices manufacturing process Michigan facility million National Security October 23 panel pathogens Phase post-marketing potential preparedness President protective antigen public health system PUTNAM question Readiness and Role require Research and Development response Role in Vaccine RYAN safety SANDERS Secretary THOMPSON September 11th SHAYS smallpox vaccine stockpile studies Subcommittee on National SUDOVAR surveillance talked terrorist testimony testing Thank therapeutics there's things TIERNEY toxin tularemia USAMRIID vaccine production Vaccine Research WELDON WINEGER
Pasajes populares
Página 3 - The dogmas of the quiet past are inadequate to the stormy present. The occasion is piled high with difficulty, and we must rise with the occasion. As our case is new, so we must think anew and act anew. We must disenthrall ourselves, and then we shall save our country.
Página 30 - I will be happy to answer any questions which you or members of the Subcommittee may have.
Página 100 - US states and 33 other nations. BIO members are involved in the research and development of health care, agricultural, industrial and environmental biotechnology products.
Página 22 - In some cases, new vaccines, antitoxins, or innovative drug treatments need to be developed, manufactured, and/or stocked. Moreover, we need to learn more about the pathogenesis and epidemiology of the infectious diseases which do not affect the US population currently. We have only limited knowledge about how artificial methods of dispersion may affect the infection rate, range of illness, and public health impact of these biological agents.
Página 22 - Services located in such places as the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and the National Institutes of Health (NIH), as well as State and local health officials.
Página 70 - BEFORE THE SUBCOMMITTEE ON NATIONAL SECURITY, VETERANS AFFAIRS AND INTERNATIONAL RELATIONS, HOUSE COMMITTEE ON GOVERNMENT REFORM ON THE STANDARD PROCUREMENT SYSTEM FEBRUARY 7, 2002 Mr.
Página 12 - Department and other agencies to support and encourage research to address scientific issues related to bioterrorism. The capability to detect and counter bioterrorism depends to a significant degree on the state of relevant medical science.
Página 15 - Before the Committee on Government Reform Subcommittee on National Security, Veterans Affairs, and International Relations United States House of Representatives November 18, 2002 Good Morning Mr.
Página 110 - Mr. Chairman and Members of the Subcommittee: I am very grateful for the opportunity to...
Página 52 - ... any action which it considers necessary for the protection of its essential security interests...